Biochemistry Division, National Veterinary Research Institute (NVRI), Vom, Nigeria.
Department of Biochemistry, Ahmadu Bello University, Zaria, Nigeria.
Front Cell Infect Microbiol. 2021 May 26;11:654813. doi: 10.3389/fcimb.2021.654813. eCollection 2021.
COVID-19 is a zoonotic disease with devastating economic and public health impacts globally. Being a novel disease, current research is focused on a clearer understanding of the mechanisms involved in its pathogenesis and viable therapeutic strategies. Oxidative stress and inflammation are intertwined processes that play roles in disease progression and response to therapy interference with multiple signaling pathways. The redox status of a host cell is an important factor in viral entry due to the unique conditions required for the conformational changes that ensure the binding and entry of a virus into the host cell. Upon entry into the airways, viral replication occurs and the innate immune system responds by activating macrophage and dendritic cells which contribute to inflammation. This review examines available literature and proposes mechanisms by which oxidative stress and inflammation could contribute to COVID-19 pathogenesis. Further, certain antioxidants currently undergoing some form of trial in COVID-19 patients and the corresponding required research gaps are highlighted to show how targeting oxidative stress and inflammation could ameliorate COVID-19 severity.
新型冠状病毒肺炎(COVID-19)是一种人畜共患疾病,对全球经济和公共卫生造成了毁灭性影响。作为一种新型疾病,目前的研究重点是更清楚地了解其发病机制和可行的治疗策略。氧化应激和炎症是相互交织的过程,在疾病进展和对治疗的反应中发挥作用,干扰多种信号通路。由于病毒进入宿主细胞所需的独特条件,确保病毒与宿主细胞结合并进入宿主细胞所需的构象变化,宿主细胞的氧化还原状态是病毒进入的一个重要因素。进入呼吸道后,病毒开始复制,先天免疫系统通过激活巨噬细胞和树突状细胞作出反应,导致炎症。本综述检查了现有文献,并提出了氧化应激和炎症可能导致 COVID-19 发病机制的机制。此外,还强调了 COVID-19 患者目前正在进行某种形式试验的某些抗氧化剂以及相应的所需研究空白,以表明靶向氧化应激和炎症如何改善 COVID-19 的严重程度。